Predictive Approaches in Drug Discovery and Development: Biomarkers and In Vitro / In Vivo Correlations

Predictive Approaches in Drug Discovery and Development: Biomarkers and In Vitro / In Vivo Correlations

by J. Andrew Williams
     
 

View All Available Formats & Editions

Practical Utility of Biomarkers in Drug Discovery and Development covers all aspects of biomarker research applied to drug discovery and development and contains state-of-the-art appraisals on the practical utility of genomic, biochemical, and protein biomarkers.  Case histories and lessons from successful and unsuccessful applications of biomarkers are

Overview

Practical Utility of Biomarkers in Drug Discovery and Development covers all aspects of biomarker research applied to drug discovery and development and contains state-of-the-art appraisals on the practical utility of genomic, biochemical, and protein biomarkers.  Case histories and lessons from successful and unsuccessful applications of biomarkers are included along with key chapters on GLP validation, safety biomarkers and proteomics biomarkers.  Regulatory agency perspectives and initiatives both in the US and internationally are also discussed.

Editorial Reviews

From the Publisher
“The ability to correlate in vitro and in vivo biomarker information in the process of drug discovery and development lies at the heart of translational research. The goal is to rapidly translate basic discoveries into clinical applications. This book provides state-of-the-art information on this exciting new research approach.”  (Doody’s, 8 February 2013)

“The text is packed with interesting, comprehensive, and pertinent information, clearly presented with salient points reinforced by inclusion in text boxes . . . This is an admirable textbook for those dealing with drug discovery and development. I enjoyed reading through it and I would recommend it to anyone who has an interest, or is developing an interest, in the field of biomarkers and their, as yet, unfulfilled potential.”  (ISSX International Society for the Study of Xenobiotics, 1 December 2012)

Doody's Review Service
Reviewer: Thomas L. Pazdernik, PhD (University of Kansas Medical Center)
Description: Translational research is a current buzz word that deals with bringing bench research to the bedside. This book in the Wiley Series on Technologies for the Pharmaceutical Industry focuses on the use of in vitro and in vivo biomarkers to facilitate drug discovery and development.
Purpose: The editors' objective is to provide a critical compilation of the most important aspects of the use of in vitro and in vivo biomarkers to facilitate translating basic pharmacology and drug effects into clinical utility and regulatory acceptance. They have done a marvelous job of bringing these correlations together.
Audience: This book is designed to be of value to all those in academia or the pharmaceutical industry who are involved in the process of new drug discovery all the way from concepts, "go-to-no-go" decision processes, and regulatory aspects.
Features: Part I deals with the use of biomarkers in drug discovery including importance, validation, and proteomic and metabolomics methods. Part II focuses on clinical applications of biomarkers including vascular biomarkers and imaging, success and failure in the prediction human safety via cardiovascular biomarkers, the use of molecular imaging for receptor occupancy for decision making in drug discovery, and the use of biosensors as clinical markers. Part III deals with regulatory perspectives and includes chapters providing European and Japanese perspectives. Part IV covers predicting responses in vivo such as in vitro/in vivo correlations of hepatic drug clearance, the potential of a combination of in silico and in vitro approaches to predict in vivo drug-drug interactions, pharmacokinetics, and toxicity; and the use of in vitro/in vivo correlations for developing concepts and applications in toxicology, plus assessing the potential for induction of cytochrome p450 enzymes and predicting in vivo metabolism.
Assessment: The ability to correlate in vitro and in vivo biomarker information in the process of drug discovery and development lies at the heart of translational research. The goal is to rapidly translate basic discoveries into clinical applications. This book provides state-of-the-art information on this exciting new research approach.

Product Details

ISBN-13:
9781118230268
Publisher:
Wiley
Publication date:
02/14/2012
Series:
Wiley Series on Technologies for the Pharmaceutical Industry , #11
Sold by:
Barnes & Noble
Format:
NOOK Book
Pages:
368
File size:
10 MB

What People are saying about this

From the Publisher
“The ability to correlate in vitro and in vivo biomarker information in the process of drug discovery and development lies at the heart of translational research. The goal is to rapidly translate basic discoveries into clinical applications. This book provides state-of-the-art information on this exciting new research approach.” (Doody’s, 8 February 2013)

“The text is packed with interesting, comprehensive, and pertinent information, clearly presented with salient points reinforced by inclusion in text boxes . . . This is an admirable textbook for those dealing with drug discovery and development. I enjoyed reading through it and I would recommend it to anyone who has an interest, or is developing an interest, in the field of biomarkers and their, as yet, unfulfilled potential.” (ISSX International Society for the Study of Xenobiotics, 1 December 2012)

Meet the Author

J. Andrew Williams, PHD, is Director of Translational Oncology at Pfizer Oncology.

Richard Lalonde, PharmD, is Vice President and Global Head of Clinical Pharmacology at Pfizer.

Jeffrey Koup, PharmD, is a consultant for PKPD modeling and the owner of Lakeside PKPD, LLC.

David D. Christ, PHD, is a consultant with SNC Partners LLC.

Customer Reviews

Average Review:

Write a Review

and post it to your social network

     

Most Helpful Customer Reviews

See all customer reviews >